Patients with fibromyalgia who have an inadequate response to duloxetine may gain additional benefit in global status and pain improvement when switched to milnacipran, according to research presented at the 2012 American Academy of Pain Medicine Annual Meeting.
Sign in with your MPR account
Keep me signed in Forgot your password?
REGISTER FOR FREE WITH A MPR ACCOUNT
Enter your MPR registration email address to receive a new password.